Ajanta Pharma Promoter Aayush Agrawal Creates and Releases Pledge on Shares
Ajanta Pharma promoter Aayush Agrawal has disclosed pledge activities involving creation of 10.43 lakh shares and release of 8.50 lakh shares under SEBI regulations. The transactions were conducted with multiple lenders including Motilal Oswal Financial Services and Ashika Credit Capital, with post-event encumbered holdings of 83.97 lakh shares representing 6.72% of total share capital.
*this image is generated using AI for illustrative purposes only.
Ajanta Pharma promoter Aayush Agrawal has disclosed the creation and release of pledge on equity shares of the company on March 26, 2026. The disclosure was made under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, with formal notifications submitted to both BSE and NSE.
Latest Pledge Transaction Details
The recent pledge transactions by Aayush Agrawal involved creation of pledge on 10,42,500 shares and release of pledge on 8,50,000 shares. According to the disclosure, the creation of pledge was undertaken for new loan purposes, while the release was attributed to loan not taken.
| Transaction Type: | Details |
|---|---|
| Pledge Creation: | 10,42,500 equity shares |
| Pledge Release: | 8,50,000 equity shares |
| Creation Reason: | For new loan |
| Release Reason: | Loan not taken |
| Disclosure Date: | March 26, 2026 |
| Regulatory Framework: | SEBI (SAST) Regulations, 2011 |
Detailed Encumbrance Activities
The disclosure document shows multiple pledge activities involving different financial institutions as lenders. Aayush Agrawal Trust had existing encumbered holdings of 82,04,162 shares representing 6.57% of total share capital before the latest transactions.
| Event Date: | Transaction Type | Shares | Percentage | Lender |
|---|---|---|---|---|
| March 23, 2026: | Pledge Creation | 8,50,000 | 0.68% | Motilal Oswal Financial Services Ltd |
| March 25, 2026: | Pledge Release | 8,50,000 | 0.68% | Motilal Oswal Financial Services Ltd |
| March 23, 2026: | Pledge Creation | 1,92,500 | 0.15% | Ashika Credit Capital Ltd |
Post-event, Aayush Agrawal Trust holds 83,96,662 encumbered shares representing 6.72% of the total share capital.
Comprehensive Promoter Holdings Structure
The detailed promoter holding disclosure reveals the comprehensive shareholding pattern of the Agrawal family and associated entities across multiple trusts and companies.
| Promoter Entity: | Shareholding | Percentage |
|---|---|---|
| Yogesh Agrawal Trust: | 1,80,78,147 shares | 14.47% |
| Rajesh Agrawal Trust: | 1,80,78,148 shares | 14.47% |
| Ravi Agrawal Trust: | 1,62,42,904 shares | 13.00% |
| Aayush Agrawal Trust: | 1,41,12,924 shares | 11.30% |
| Gabs Investments Pvt Ltd: | 1,25,88,393 shares | 10.08% |
| Ganga Exports: | 33,48,261 shares | 2.68% |
Regulatory Compliance
The disclosure fulfills the mandatory reporting requirements under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The formal communication was addressed to both stock exchanges where Ajanta Pharma shares are listed, ensuring complete regulatory compliance and transparency in promoter shareholding changes. Aayush Agrawal, acting as trustee of Aayush Agrawal Trust, submitted the required documentation with proper authorization and signatures.
Historical Stock Returns for Ajanta Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.10% | -3.43% | -6.31% | +13.79% | +6.68% | +125.90% |
What strategic initiatives or expansion plans might Ajanta Pharma be considering that would require the promoter to secure new loans against equity shares?
How might the increased pledge percentage from 6.57% to 6.72% impact investor confidence and the company's stock price performance in the coming quarters?
Will other promoter entities within the Agrawal family follow similar pledging strategies to raise capital for business investments?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
